KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Edgewell Personal Care (EPC) Research & Development (2016 - 2025)

Edgewell Personal Care (EPC) has disclosed Research & Development for 17 consecutive years, with $14.0 million as the latest value for Q2 2025.

  • On a quarterly basis, Research & Development fell 4.11% to $14.0 million in Q2 2025 year-over-year; TTM through Jun 2025 was $58.1 million, a 0.17% change, with the full-year FY2024 number at $58.4 million, changed 0.17% from a year prior.
  • Research & Development was $14.0 million for Q2 2025 at Edgewell Personal Care, down from $14.4 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $16.3 million in Q3 2024 to a low of $12.8 million in Q4 2021.
  • A 5-year average of $14.4 million and a median of $14.4 million in 2021 define the central range for Research & Development.
  • Peak YoY movement for Research & Development: grew 17.74% in 2021, then decreased 6.85% in 2022.
  • Edgewell Personal Care's Research & Development stood at $12.8 million in 2021, then grew by 4.69% to $13.4 million in 2022, then decreased by 0.75% to $13.3 million in 2023, then increased by 0.75% to $13.4 million in 2024, then increased by 4.48% to $14.0 million in 2025.
  • Per Business Quant, the three most recent readings for EPC's Research & Development are $14.0 million (Q2 2025), $14.4 million (Q1 2025), and $13.4 million (Q4 2024).